Is Edgewell Personal Care (EPC) Undervalued As Its Share Price Rally Tests Analyst Targets?
Edgewell Personal Care (EPC) has drawn fresh attention after recent share price gains, with the stock up over the past month and past 3 months, prompting investors to reassess its fundamentals and valuation.
See our latest analysis for Edgewell Personal Care.
Beyond the latest move, Edgewell Personal Care’s 28.83% 30 day share price return and 73.07% year to date share price return indicate building momentum, even though the 3 year and 5 year total shareholder returns remain negative.
If recent gains in Edgewell Personal Care have you thinking about where else momentum could emerge, it may be worth scanning 18 top founder-led companies.
Edgewell Personal Care shares have risen sharply, yet the stock still screens at a large estimated discount to intrinsic value while trading above analyst targets. Is the market being too cautious, or seeing risks others are overlooking?
Most Popular Narrative: 19.1% Overvalued
Analysts putting fair value for Edgewell Personal Care at $24.50 are well below the recent $29.18 share price, which naturally raises questions about what assumptions sit behind that gap.
Edgewell is aggressively investing in brand innovation and targeted marketing campaigns (e.g., digital-first initiatives with Hawaiian Tropic and Cremo, new Hydro Silk packaging/campaign), which are already driving market share gains across core brands and should support above-category sales growth and improved pricing/mix, positively impacting future revenue and gross margins.
Curious how a company with declining forecast revenue can still be modeled to grow earnings sharply and justify that fair value? The widely followed narrative leans heavily on margin rebuild, cash flow improvement and a relatively low future earnings multiple. The real story is in how those ingredients are expected to interact over several years.
Result: Fair Value of $24.50 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Edgewell Personal Care still faces pressure from mature categories and stronger retailer bargaining power. This could weigh on volumes, pricing and the margin rebuild story.
Find out about the key risks to this Edgewell Personal Care narrative.
Another View on Edgewell Personal Care’s Valuation
The narrative based on analyst targets suggests Edgewell Personal Care is 19.1% overvalued at $29.18 versus a fair value of $24.50. Yet Simply Wall St’s DCF model points the other way, with the stock trading at a large discount to an estimated future cash flow value of $79.13. That is a wide gap in implied outcomes, so which set of assumptions feels more realistic to you?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
With mixed signals around Edgewell Personal Care’s valuation, are you seeing more risk or opportunity here, and how quickly do you want to act on that view? To weigh both sides of the argument, including the specific concerns and potential upsides investors are focusing on, start with the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Edgewell Personal Care?
Once you have a view on Edgewell Personal Care, do not stop there. The market rarely rewards tunnel vision and fresh ideas can shift your portfolio’s balance.
- Target potential underpriced opportunities by scanning for quality companies trading below their estimated value through the 49 high quality undervalued stocks.
- Strengthen your income stream by focusing on companies that aim to offer higher yields and resilient payouts using the 8 dividend fortresses.
- Prioritise resilience by filtering for companies with strong financial footing and robust fundamentals via the solid balance sheet and fundamentals stocks screener (48 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com